Navigation Links
NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
Date:1/13/2010

DURHAM, N.C., Jan. 13 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) announced today that the company's common stock will begin trading on the NASDAQ Capital Market with the opening of trading on Friday, January 15, 2010. The shares will continue to trade under the symbol OXBT.

In addition, company chairman and CEO Chris Stern will be in New York to ring the opening bell at the NASDAQ one week later on Friday, January 22.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine™. The company has developed a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte™) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes wounds and ulcers, and cosmetic applications which are being marketed under the Dermacyte name. More information is available at www.oxybiomed.com.

SOURCE Oxygen Biotherapeutics, Inc.

RELATED LINKS
'/>"/>

SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
2. VIA Pharmaceuticals Receives Delisting Notification From NASDAQ
3. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
4. Mylan Added to NASDAQ-100 Index
5. Dynatronics Receives 180-Day NASDAQ Extension
6. China Biologic Products Approved to List on NASDAQ
7. Henry Schein to Present at the NASDAQ OMX 23rd Investor Program
8. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
9. Hologic to Present at NASDAQ OMX 23rd Investor Program in London
10. Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing
11. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  Lehigh Valley Health Network ... TM devices, adding to its existing arsenal of ... taking up residence within the network, LVHN is now ... to proactively combat superbugs and provide the best possible ... Room Ultraviolet Disinfector, TRU-D – the signature product of ...
(Date:5/21/2013)... SUNNYVALE, Calif. , May 21, 2013 /PRNewswire/ ... ), announced today the publication of study results ... the CyberKnife® Robotic Radiosurgery System, the most widely ... (SBRT). The study followed 304 patients for a ... years post-treatment and found that 97 percent of ...
(Date:5/21/2013)... 21, 2013  Janssen R&D Ireland (Janssen) today ... global Phase 3 PROMISE study demonstrating that use ... to sustained virologic response 12 weeks after the ... treatment-experienced genotype 1 chronic hepatitis C adult patients ... liver fibrosis, when administered once daily with pegylated ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7
(Date:5/21/2013)... 21, 2013 Five million Americans will ... who do, Tiffany Liashek, owner of Studio South ... a long look at credentials and experience. The variation ... she says. “A trainer can pay $69.50 and get ... , Good trainers invest in themselves, A serious, professional ...
(Date:5/21/2013)... 2013 Third Generation Master Barber Greg ... first two barbering DVDs. These DVDs include content from ... school , cosmetology school or are current professionals, will ... an experienced teacher and mentor. , Today’s modern men’s ... 1920’s – 1960’s time period. In order to efficiently ...
(Date:5/21/2013)... May 21, 2013 Dallas-based TopMD™ Skin ... journal article testing the efficacy of their flagship product, ... The clinical study results appear in the May/June 2013 ... article, “A Novel Sodium Hypochlorite Cleanser Shows Clinical Response ... reports impressive findings seen after consistent use of the ...
(Date:5/21/2013)... Everspark Interactive, one of the city's leading online marketing ... past year – and announced another milestone this week ... for Kids II, a designer of innovative baby toys ... effort, specializing in search engine optimization (SEO) or the ... The company now offers a host of boutique online ...
(Date:5/21/2013)... Beginning May 21st, 2013, DTP Sales ... 8000, the newest in digital recording technology, to the ... product for anyone looking to get the most from ... 8000 is expected to have revolutionary options and ... voice recorder features and highlights: , ...
Breaking Medicine News(10 mins):Health News:Sarasota Fitness Tips: Choosing a Safe Trainer and Gym 2Health News:Sarasota Fitness Tips: Choosing a Safe Trainer and Gym 3Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 2Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 3Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 4Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 5Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 6Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 3Health News:Everspark Named Interactive Marketing Company for Kids II 2Health News:DTP Sales & Service Announces Upcoming Availability Of Philips Pocket Memo 8000 Series 2
... They could fight cancer, heart disease, researchers say , , MONDAY, ... your life, a new European study suggests. , "The ... mortality from any cause of death," said lead researcher Dr. ... in Lyon, France. , The new finding, published in the ...
... the Association for Assessment and Accreditation of Laboratory ... standard for animal care facilities, AAALAC accreditation is ... the humane care and use of animals in ... involves a comprehensive review by AAALAC evaluators, who ...
... out-of-pocket health care costs, CAMP HILL, Pa., Sept. ... to help consumers compare health plan options and,choose one ... is available,to consumers on Highmark member Web sites. ... said Kim,Bellard, Vice President of eMarketing and Customer Relationship ...
... 10 portionpals(R), the fastest growing,weight loss tool ... million,sales mark with no national retail distribution in ... are coming strictly from word-of-mouth," says Matt,Zucker, VP ... Moose,of Manistique, Michigan became our 250,000 customer! "Our ...
... researchers have found that first-degree relatives (i.e., parents, siblings, ... more likely to have the biomarker of the disease ... could screen and assess first-degree relatives of PBC patients ... and treat more patients before the disease causes irreversible ...
... well after therapy ends , , MONDAY, Sept. 10 (HealthDay ... breast cancer survivors still report more days of fatigue ... fatigue is likely a long-term effect of chemotherapy, according ... complaint for most people and is also reported by ...
Cached Medicine News:Health News:Vitamin D Supplements May Lengthen Life 2Health News:UCSF animal care facility receives top accreditation 2Health News:Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers 2Health News:New research may lead to earlier diagnosis and treatment of primary biliary cirrhosis in families 2Health News:Long-Term Fatigue Plagues Cancer Survivors 2
... Sun Design chairs offer support and ... of the chair are designed to take ... maximum comfort. The seat height and angle ... a single lever. The seat can be ...
Heine Beta 200 Streak Retinoscope 2.5v...
Video Equipment...
Portable mini halogen light....
Medicine Products: